Physician profile
Hee Yang
NPI 1174559280
$16,644.74
in general payments reported to CMS, 2019-2025
9 companies · $1,712 in 2025
The $1,712 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $14.00 · 2021: $239 · 2022: $2,045 · 2023: $8,366 · 2024: $3,320 · 2025: $1,712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $8,317 · Travel and Lodging: $3,500 · Food and Beverage: $1,573 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $8,316.75 |
| Travel and Lodging | $3,500.29 |
| Food and Beverage | $1,572.58 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,570.59 | 2021-2025 | Signia, Venaseal |
| Intuitive Surgical, INC. | $6,041.46 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $1,468.42 | 2024 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Ethicon US, LLC | $180.20 | 2019-2021 | |
| Tela Bio, INC. | $170.96 | 2021 | |
| Olympus America INC. | $146.08 | 2024-2025 | Olympus |
| Boston Scientific Corporation | $29.58 | 2023 | Spyglass Discover |
| Sanara Medtech INC. | $22.70 | 2024 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $14.75 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hee Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.